Company: VRCA
Filing Date: 2025-03-11
Form Type: S-3
Source: 0001193125-25-052031
Chunk: 0

Company: Verrica Pharmaceuticals Inc.
Filing Date: 2025-03-11
Form: S-3
Chunk 0
---
As filed with the Securities and Exchange Commission on March 11, 2025 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Verrica Pharmaceuticals Inc. (Exact name of registrant as specified in its charter)

| Delaware                        |     | 46-3137900            |
| (State or other jurisdiction of 
 incorporation or organization)  |     | -I.R.S. Employer      
 Identification Number |

44 W. Gay St., Suite 400 West Chester, PA, 19380 (484) 453-3300 (Address, including zip code, and telephone number, including area code of registrant’s principal executive offices) Jayson Rieger President and Chief Executive Officer Verrica Pharmaceuticals Inc. 44 W. Gay St., Suite 400 West Chester, PA 19380 (484) 453-3300 (Name, address, including zip code, and telephone number, including area code, of agent for service) Copies to: Mark Ballantyne Darren DeStefano Asheley Walker Cooley LLP 11951 Freedom Drive Reston, Virginia 20190 (703) 456-8000 From time to time after the effective date of this Registration Statement (Approximate date of commencement of proposed sale to the public) If the only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment plans, please check the following box. ☐ If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, other than securities offered only in connection with dividend or interest reinvestment plans, check the following box. ☒ If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐ If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐ If this Form is a registration statement pursuant to General Instruction I.D. or a post-effective amendment thereto that shall become effective upon filing with the Commission pursuant to Rule 462(e) under the Securities Act,